MARS Bioimaging

MARS Bioimaging Ltd (MBI) was established in 2007 to commercialize the groundbreaking MARS imaging system for medical diagnostics. The MARS imaging system is based on the next-generation Medipix chips licensed from CERN in Switzerland and technology developed by the University of Canterbury (UC) and its partners. It has become the world's leading spectral imaging technology. It is the first commercialized spectral, high-definition computed tomography (CT) system and has already demonstrated exciting applications.